Date:3/5/2010

(1,816,785) 1,847,806 Stock-based compensation 41,804 123,794 Changes in assets and liabilities: Trade accounts receivable (13,366,578) (17,778,209) Other receivables 136,587 265,813 Advances to suppliers 1,240,118 (87,978) Inventory (1,060,083) 2,243,138 Deferred tax assets 142,846 (257,447) Trade accounts payable 3,044,387 720,659 Accrued expenses (8,775) (219,301) Accrued taxes payable 355,587 825,119 Other payables 15,274 (48,072) Other payables-related parties -- (52,804) Advances from customers 342,607 407,617 Net Cash Provided by Operating Activities 10,668,926 6,543,260 Cash Flows from Investing Activities Purchase of property and equipment (143,082) (4,310,690) Construction in progress -- -- Purchase of intangible assets (12,154,561) (4,184,080) Advances for intangible assets and property and equipment (3,063,066) (1,946,479) Net Cash Used in Investing Activities (15,360,709) (10,441,249) Cash Flows from Financing Activities Proceeds from exercise of warrants 70,001 -- Proceeds from sale of common stock -- 9,268,938 Proceeds from short-term notes payable 3,800,681 2,441,739 Payments of short-term notes payable (2,485,060) (2,829,545) Net Cash P
'/>"/>

SOURCE China Pharma Holdings, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13
Related medicine technology :

1. China Biologic Products to Present at the Rodman & Renshaw Annual China Investment Conference
2. China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2009 Financial Results
3. China Nepstar Chain Drugstore Announces Annual Dividend
4. Chinas leading electronic systems design event to highlight next-generation medical, automotive and green power technologies
5. QRxPharma Limited and China Aoxing Pharmaceutical Company Announce Strategic Alliance for Development of MoxDuo(R)IV
6. OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China
7. Simcere Receives SFDA Approval to Manufacture and Sell Zanamivir in China
8. Candela Receives Registration Approval to Market Its Best-in-Class GentleMax and Alex TriVantage Lasers in China
9. Gorbec Pharmaceutical Services, Inc. Announces the Launch of Its GMP Analytical Laboratory in China
10. Chinas Basic Medical Insurance to Cover Sinobiopharmas Flagship Product
11. China Sky One Medical, Inc. Completes and Moves into New Corporate Headquarters